Showing results 7 to 13 of 13
< previous
Title | Author(s) | Issue Date | |
---|---|---|---|
Modulation of angiogenic biomarkers in patients receiving high-dose TRC105 Proceeding/Conference:Journal of Clinical Oncology | 2012 | ||
7-Mar-2014 | |||
2012 | |||
A phase I study of ABT-510 plus bevacizumab in advanced solid tumors Journal:Cancer Medicine | 2013 | ||
Phase I study of capecitabine, oxaliplatin, bevacizumab, and everolimus in advanced solid tumors Journal:Invest New Drugs | 2014 | ||
A Phase I/biomarker study of bevacizumab in combination with CNTO 95 in patients with advanced solid tumors Journal:Cancer Chemotherapy and Pharmacology | 2015 | ||
2013 |